Ponatinib | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Ponatinib
US Exclusivities

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Ponatinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 3 USDMF, 2 EU WC, 4 NDC API, 7 Listed Suppliers, $ API Reference Price

10 API Suppliers
3 USDMF
2 EU WC
4 NDC API
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 6 FDA Orange Book, 10 Europe, 1 Canada, 6 Australia

23 FDF Dossiers
6 FDA Orange Book
10 Europe
1 Canada
6 Australia

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 15MG BASE, TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 45MG BASE

TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 15MG BASE
TABLET;ORAL - EQ 30MG BASE
TABLET;ORAL - EQ 45MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 17 Kerry, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Vasa Pharmachem

1 SPI Pharma
1 DKSH
2 Faran Shimi Pharmaceutical
3 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
4 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
17 Kerry
9 Microlex e.U
1 Pharmatrans-Sanaq
2 Pluviaendo
2 Prachin Chemical
7 Roquette
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
9 Sigachi Industries
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 11 Direct Compression, 10 Lubricants & Glidants, 10 Thickeners and Stabilizers, 8 Granulation, 7 Co-Processed Excipients, 4 Disintegrants & Superdisintegrants, 3 Controlled & Modified Release, 3 Emulsifying Agents, 2 Coating Systems & Additives, 2 Taste Masking, 2 Chewable & Orodispersible Aids, 1 Parenteral, 1 Film Formers & Plasticizers, 1 API Stability Enhancers, 1 Rheology Modifiers

36 Fillers, Diluents & Binders
11 Direct Compression
10 Lubricants & Glidants
10 Thickeners and Stabilizers
8 Granulation
7 Co-Processed Excipients
4 Disintegrants & Superdisintegrants
3 Controlled & Modified Release
3 Emulsifying Agents
2 Coating Systems & Additives
2 Taste Masking
2 Chewable & Orodispersible Aids
1 Parenteral
1 Film Formers & Plasticizers
1 API Stability Enhancers
1 Rheology Modifiers

DIGITAL CONTENT

1 STOCK RECAP #PipelineProspector, 35 NEWS #PharmaBuzz

1 STOCK RECAP #PipelineProspector
35 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 7 Finished Drug Prices, 8 Annual Reports

1 US Medicaid Prescriptions
7 Finished Drug Prices
8 Annual Reports

MARKET PLACE

4 APIs, 2 FDF Dossiers

4 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

68 US Patents, 8 US Exclusivities, 2 Health Canada Patents

68 US Patents
8 US Exclusivities
2 Health Canada Patents

$ API Ref.Price (USD/KG) : 84,930 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

8 All

01 8TAKEDA PHARMS USA

filter Product Reset all filters

8 All

01 8PONATINIB HYDROCHLORIDE

filter Exclusivity Expiration Date Reset all filters

8 All

01 42027-03-19

02 42031-03-19

filter Exclusivity Code Reset all filters

8 All

01 4I-934

02 4ODE-472

Product Main Page

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

3

Exclusivity Details

01

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

BioAsia

Not Confirmed

TAKEDA PHARMS USA

Japan

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

2

Exclusivity Details

02

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

BioAsia

Not Confirmed

TAKEDA PHARMS USA

Japan

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

2

Exclusivity Details

03

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

BioAsia

Not Confirmed

TAKEDA PHARMS USA

Japan

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

1

Exclusivity Details

04

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

BioAsia

Not Confirmed

TAKEDA PHARMS USA

Japan

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

1

Exclusivity Details

05

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

BioAsia

Not Confirmed

TAKEDA PHARMS USA

Japan

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

4

Exclusivity Details

06

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

BioAsia

Not Confirmed

TAKEDA PHARMS USA

Japan

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

4

Exclusivity Details

07

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

BioAsia

Not Confirmed

TAKEDA PHARMS USA

Japan

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

3

Exclusivity Details

08

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

BioAsia

Not Confirmed

TAKEDA PHARMS USA

Japan

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!